Atara Biotherapeutics
ATRA
Insider trades and stock quote 2024-2026
All insider trades at Atara Biotherapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
9/4/2026
|
Buy |
Cherry, Brian N. |
Director |
$9.6 |
$999,994 |
|
8/17/2026
|
Sell |
Nguyen, Anhco |
President and CEO |
$8.1 |
$40,883 |
|
5/18/2026
|
Sell |
Grant-Huerta, Yanina |
Chief Accounting Officer |
$9.1 |
$22,036 |
|
5/18/2026
|
Sell |
Nguyen, Anhco |
President and CEO |
$9.1 |
$47,845 |
|
5/7/2026
|
Buy |
Ecor1 Capital, LLC |
Ten Percent Owner |
$9.4 |
$4,744,255 |
|
5/7/2026
|
Sell |
Panacea Innovation Ltd |
Ten Percent Owner |
$10.1 |
$3,165,021 |
|
3/2/2026
|
Sell |
Nguyen, Anhco |
President and CEO |
$5.1 |
$15,238 |
|
3/2/2026
|
Sell |
Grant-Huerta, Yanina |
Chief Accounting Officer |
$5.1 |
$10,691 |
|
1/12/2026
|
Sell |
Panacea Innovation Ltd |
Ten Percent Owner |
$6.1 |
$489,019 |
|
11/17/2025
|
Sell |
Grant-Huerta, Yanina |
Chief Accounting Officer |
$13.2 |
$23,788 |
|
11/17/2025
|
Sell |
Nguyen, Anhco |
President and CEO |
$13.2 |
$38,438 |
|
8/18/2025
|
Sell |
Grant-Huerta, Yanina |
Chief Accounting Officer |
$11.6 |
$21,009 |
|
8/18/2025
|
Sell |
Nguyen, Anhco |
President and CEO |
$11.6 |
$34,361 |
|
8/15/2025
|
Buy |
Panacea Innovation Ltd |
Ten Percent Owner |
$12.2 |
$670,423 |
|
7/17/2025
|
Buy |
Panacea Innovation Ltd |
Ten Percent Owner |
$9.6 |
$186,372 |
|
5/16/2025
|
Sell |
Nguyen, Anhco |
President and CEO |
$6.8 |
$22,156 |
|
5/16/2025
|
Sell |
Grant-Huerta, Yanina |
Chief Accounting Officer |
$6.8 |
$15,000 |
|
3/3/2025
|
Sell |
Henrich, Jill |
EVP, Chief Regulatory Officer |
$7.0 |
$7,410 |
|
3/3/2025
|
Sell |
Hyllengren, Eric J. |
EVP, CFO and COO |
$7.0 |
$8,473 |
|
3/3/2025
|
Sell |
Nguyen, Anhco |
President and CEO |
$7.0 |
$23,307 |
|
11/18/2024
|
Sell |
Nguyen, Anhco |
President and CEO |
$11.2 |
$18,633 |
|
11/18/2024
|
Sell |
Hyllengren, Eric J. |
EVP, CFO and COO |
$11.2 |
$15,274 |
|
11/18/2024
|
Sell |
Henrich, Jill |
EVP, Chief Regulatory Officer |
$11.2 |
$11,198 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now